NASDAQ:PETS PetMed Express (PETS) Stock Forecast, Price & News $15.33 -0.32 (-2.04%) (As of 11:10 AM ET) Add Compare Share Share Today's Range$15.24▼$15.6550-Day Range$14.61▼$16.5652-Week Range$14.05▼$24.01Volume84,891 shsAverage Volume423,792 shsMarket Capitalization$324.54 millionP/E Ratio766.88Dividend Yield7.83%Price Target$18.50 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media PetMed Express MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside18.2% Upside$18.50 Price TargetShort InterestBearish22.20% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment1.24Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth10.91%From $0.55 to $0.61 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.70 out of 5 starsRetail/Wholesale Sector148th out of 208 stocksDrug Stores & Proprietary Stores Industry3rd out of 6 stocks 2.0 Analyst's Opinion Consensus RatingPetMed Express has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.50, PetMed Express has a forecasted upside of 18.2% from its current price of $15.65.Amount of Analyst CoveragePetMed Express has only been the subject of 2 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted22.20% of the outstanding shares of PetMed Express have been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.Change versus previous monthShort interest in PetMed Express has recently increased by 0.21%, indicating that investor sentiment is decreasing. Previous Next 1.7 Dividend Strength Dividend LeadershipPetMed Express is a leading dividend payer. It pays a dividend yield of 7.84%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of PetMed Express is 6,003.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 196.72% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PETS. Previous Next 3.5 News and Social Media Coverage News SentimentPetMed Express has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Retail/Wholesale companies.News Coverage This WeekMarketBeat has tracked 5 news articles for PetMed Express this week, compared to 4 articles on an average week.Search InterestOnly 19 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.MarketBeat Follows11 people have added PetMed Express to their MarketBeat watchlist in the last 30 days. This is an increase of 120% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.10% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions77.74% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for PetMed Express are expected to grow by 10.91% in the coming year, from $0.55 to $0.61 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is 782.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 131.65.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is 782.89, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 32.83.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About PetMed Express (NASDAQ:PETS) StockPetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.Read More Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Email Address PETS Stock News HeadlinesJune 1, 2023 | marketbeat.comChewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come (PETS)Chewy.com gave the market what it wanted and now the shares are surging. Short interest may drive volatility bt the reversal is on.May 23, 2023 | marketbeat.comPetMed Express: Charts Say This Could Be The Bottom PetMed Express has a high 8% yield that comes with risk. The company is on track with a turnaround, and the institutions have been buying.June 8, 2023 | Edge On The Street (Ad)Graphite Shortage Could Derail the $7 Trillion EV TransitionGraphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.June 1, 2023 | finance.yahoo.comPetMed Express to Present at the RBC Capital Markets Consumer DayMay 31, 2023 | msn.comPetMed Express: Dividend InsightsMay 26, 2023 | americanbankingnews.comPetMed Express (NASDAQ:PETS) Now Covered by Analysts at Lake Street CapitalMay 25, 2023 | msn.comPetMed Express's Return On Capital Employed InsightsMay 24, 2023 | msn.comPetmed Express (PETS) Declares $0.30 DividendJune 8, 2023 | Edge On The Street (Ad)Graphite Shortage Could Derail the $7 Trillion EV TransitionGraphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.May 23, 2023 | finanznachrichten.dePetMed Express, Inc.: PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per ShareMay 23, 2023 | msn.comPetMed Skids on Q4 DisappointmentMay 23, 2023 | msn.comPetMed stock slides on surprise quarterly lossMay 23, 2023 | finance.yahoo.comQ4 2022 Petmed Express Inc Earnings CallMay 23, 2023 | americanbankingnews.comPetMed Express (NASDAQ:PETS) Releases Earnings ResultsMay 23, 2023 | americanbankingnews.comPetMed Express, Inc. (NASDAQ:PETS) Announces $0.30 Quarterly DividendMay 23, 2023 | americanbankingnews.comPetMed Express (NASDAQ:PETS) Issues Earnings Results, Misses Estimates By $0.39 EPSMay 22, 2023 | nasdaq.comPetMed Express Inc. Q4 Earnings SummaryMay 22, 2023 | msn.comUnusual Call Option Trade in Petmed Express (PETS) Worth $80.31KMay 22, 2023 | seekingalpha.comPetMed Express GAAP EPS of -$0.25 misses by $0.39, revenue of $62.4M misses by $3.35MMay 22, 2023 | finance.yahoo.comPetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per ShareMay 22, 2023 | finance.yahoo.com2 Stocks to Watch on a Quiet Market DayMay 22, 2023 | americanbankingnews.comPetMed Express (NASDAQ:PETS) Now Covered by StockNews.comMay 20, 2023 | americanbankingnews.comPetMed Express (PETS) to Release Earnings on MondayMay 18, 2023 | finance.yahoo.comPetMeds® Appoints Sandra Y. Campos to its Board of DirectorsMay 18, 2023 | msn.com'No generics' deals blocked pet owners from cheaper flea-and-tick treatment, lawsuit claimsMay 18, 2023 | finance.yahoo.com2 High-Yield Dividend Stocks Billionaires Can't Stop BuyingMay 11, 2023 | msn.comPet-friendly private jet firm aims to make travel with dogs and cats easier: 'Cost is comparable'See More Headlines PETS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PETS Company Calendar Last Earnings5/22/2023Ex-Dividend for 6/12 Dividend6/05/2023Today6/08/2023Dividend Payable6/12/2023Next Earnings (Estimated)7/24/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Drug stores & proprietary stores Sub-IndustryInternet Retail SectorRetail/Wholesale Current SymbolNASDAQ:PETS CUSIP71638210 CIK1040130 Webwww.1800petmeds.com Phone(561) 526-4444Fax561-526-4445Employees219Year Founded1996Price Target and Rating Average Stock Price Forecast$18.50 High Stock Price Forecast$20.00 Low Stock Price Forecast$17.00 Forecasted Upside/Downside+18.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.02 Trailing P/E Ratio782.89 Forward P/E Ratio28.45 P/E GrowthN/ANet Income$230,000.00 Net Margins0.09% Pretax Margin0.62% Return on Equity4.90% Return on Assets3.95% Debt Debt-to-Equity RatioN/A Current Ratio3.60 Quick Ratio3.08 Sales & Book Value Annual Sales$256.86 million Price / Sales1.29 Cash Flow$0.56 per share Price / Cash Flow27.86 Book Value$5.87 per share Price / Book2.67Miscellaneous Outstanding Shares21,170,000Free Float20,303,000Market Cap$331.31 million OptionableOptionable Beta0.63 Social Links Key ExecutivesMatthew N. HulettPresident, Chief Executive Officer & DirectorChristine ChambersChief Financial Officer & TreasurerMark MoseleyChief Technology & Information OfficerEddie KhoriatyDir-Pharmacy Services & Prescription Dept. ManagerDan PingreeChief Marketing OfficerKey CompetitorsRite AidNYSE:RADNathan's FamousNASDAQ:NATHBuild-A-Bear WorkshopNYSE:BBWVillage Super MarketNASDAQ:VLGEADestination XL GroupNASDAQ:DXLGView All CompetitorsInstitutional OwnershipProShare Advisors LLCSold 38,179 shares on 5/26/2023Ownership: 2.641%Royce & Associates LPBought 27,975 shares on 5/23/2023Ownership: 0.243%Toroso Investments LLCBought 2,658 shares on 5/23/2023Ownership: 0.223%Ameriprise Financial Inc.Sold 9,929 shares on 5/22/2023Ownership: 0.414%New York State Common Retirement FundSold 5,700 shares on 5/18/2023Ownership: 0.044%View All Institutional Transactions PETS Stock - Frequently Asked Questions Should I buy or sell PetMed Express stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares. View PETS analyst ratings or view top-rated stocks. What is PetMed Express' stock price forecast for 2023? 2 analysts have issued 12-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $17.00 to $20.00. On average, they predict the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price. View analysts price targets for PETS or view top-rated stocks among Wall Street analysts. How have PETS shares performed in 2023? PetMed Express' stock was trading at $17.70 at the beginning of 2023. Since then, PETS stock has decreased by 11.6% and is now trading at $15.65. View the best growth stocks for 2023 here. When is PetMed Express' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, July 24th 2023. View our PETS earnings forecast. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings data on Monday, May, 22nd. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of $0.14 by $0.39. The company earned $62.41 million during the quarter, compared to the consensus estimate of $69.93 million. PetMed Express had a net margin of 0.09% and a trailing twelve-month return on equity of 4.90%. During the same quarter last year, the company earned $0.30 earnings per share. How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express? PetMed Express declared a quarterly dividend on Monday, May 22nd. Stockholders of record on Tuesday, June 6th will be paid a dividend of $0.30 per share on Monday, June 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.67%. The ex-dividend date is Monday, June 5th. Read our dividend analysis for PETS. What ETFs hold PetMed Express' stock? ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Timothy Plan Market Neutral ETF (TPMN), Formidable ETF (FORH), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Global SuperDividend US ETF (DIV), Amplify Online Retail ETF (IBUY), ProShares Russell 2000 Dividend Growers ETF (SMDV), Roundhill Acquirers Deep Value ETF (DEEP) and RiverFront Dynamic US Dividend Advantage ETF (RFDA). Is PetMed Express a good dividend stock? PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.18%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,003.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 196.72% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for PETS. What is Mendo Akdag's approval rating as PetMed Express' CEO? 5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU). What is PetMed Express' stock symbol? PetMed Express trades on the NASDAQ under the ticker symbol "PETS." Who are PetMed Express' major shareholders? PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.37%), State Street Corp (4.74%), Renaissance Technologies LLC (4.59%), Mirae Asset Global Investments Co. Ltd. (3.32%), Dimensional Fund Advisors LP (3.15%) and ProShare Advisors LLC (2.65%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn. View institutional ownership trends. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PetMed Express' stock price today? One share of PETS stock can currently be purchased for approximately $15.65. How much money does PetMed Express make? PetMed Express (NASDAQ:PETS) has a market capitalization of $331.31 million and generates $256.86 million in revenue each year. The company earns $230,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. How many employees does PetMed Express have? The company employs 219 workers across the globe. How can I contact PetMed Express? PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445. This page (NASDAQ:PETS) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.